cetylpyridinium chloride anhydrous has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhagat, G; Furman, RR; Gardner, JR; Gonen, M; Gueorguiev, VD; Heaney, ML; Manova, K; O'Connor, OA; Paoluzzi, L; Scotto, L | 1 |
Blonski, JZ; Gora-Tybor, J; Jamroziak, K; Jesionek-Kupnicka, D; Krawczynska, A; Lech-Maranda, E; Robak, T; Szmigielska-Kaplon, A; Wierzbowska, A | 1 |
Benet, I; Calvete, JJ; Dopazo, J; Farrás, R; García-Conde, J; Jantus Lewintre, E; José Terol, M; Marín, M; Montaner, D; Reinoso Martín, C | 1 |
Bilban, M; Chott, A; Demirtas, D; Döhner, H; Fonatsch, C; Gaiger, A; Heintel, D; Heller, G; Jäger, U; Kainz, B; Kienle, D; Kröber, A; Krömer-Holzinger, E; Le, T; Schwarzinger, I; Shehata, M; Stilgenbauer, S; Wagner, O; Zielinski, C; Zöchbauer-Müller, S | 1 |
4 other study(ies) available for cetylpyridinium chloride anhydrous and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Boronic Acids; Bortezomib; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Membrane Potential, Mitochondrial; Mice; Microscopy, Confocal; Molecular Mimicry; Nitrophenols; Piperazines; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Sulfonamides; Tissue Donors; Xenograft Model Antitumor Assays | 2008 |
Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow; Cell Movement; Endothelial Cells; Female; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Prognosis | 2009 |
Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.
Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; DNA-Binding Proteins; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Proto-Oncogene Proteins c-bcl-6 | 2009 |
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
Topics: Alleles; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Line, Tumor; Chromosomes, Human, Pair 7; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Gene Expression Regulation, Neoplastic; Genomic Imprinting; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nuclear Proteins; Polysaccharides; Proteins; Risk Factors; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering; Survival Rate; Ubiquitin-Protein Ligases | 2007 |